View all veterinary jobs
VetSurgeon.org publishes a curated feed of veterinary news for practising veterinary surgeons, with a primary focus on the UK profession.
We select stories based on their practical relevance, clinical interest, or professional significance — filtering out noise so busy vets can stay informed quickly.
Our coverage includes:
We report across all areas of practice, including companion animal, farm, equine and exotic species.
Our editorial approach is deliberately selective and concise. We prioritise clarity and relevance over volume, aiming to make each story worth your time.
You can follow VetSurgeon News by subscribing to the daily, weekly or monthly email digest, or via our channels on Facebook and LinkedIn.
The materials include eye-catching waiting room bunting, wall displays, posters, leaflets and leaflet holders which offer hints and tips on how to look after pets while fireworks are going off.
Ceva is also launching a series of eight three-minute fireworks videos which offer advice to owners about how they can 'Help take the fear out of fireworks' and more information about Adaptil and Feliway. The videos are presented by Emma Carr, training and charity key account manager at Ceva Animal Health and are available to download via Vimeo and Ceva’s social media tool kit.
Veterinary practices are being encouraged to use the new materials to take part in Ceva’s annual fireworks waiting room display competition, which offers a £200 voucher for the overall best display and luxury chocolate hampers for 10 runners up (hint: entrants get additional credit if they build a display den and plug in an Adaptil Calm Home Diffuser nearby).
Practices taking part in the competition can post pictures of their dens and waiting room displays on Ceva Animal Health UK's Facebook page in October.
Abigail King, senior behaviour product manager at Ceva Animal Health, said: "The extensive marketing support we are putting behind Adaptil and Feliway in the run up to the fireworks season will help educate pet owners on the measures that can be put in place to help their pets with firework fears, while highlighting the benefits of our products."
For further information, or to request the new waiting room material, contact your local account manager or email: cevauk@ceva.com.
Part of the Pets at Home Vet Group, the new centre was originally set for a Spring/Summer 2020 opening, but the COVID-19 pandemic and subsequent lockdown set launch plans back to later in the year.
The 24/7 referral centre, which is led by Dr Sam Woods and Professor Dick White as co-Clinical Directors, takes referrals in orthopaedics, internal medicine, neurology, soft tissue surgery, diagnostic imaging and anaesthesia.
Sam said: "We are thrilled to finally be able to officially open our centre this week and to start welcoming patients from the surrounding area and throughout Scotland.
"This has been a strange and difficult year for us all, and as a profession we have faced some hard months. We hope our new referral hospital will be a great asset to the local first opinion professionals, as an extra support with any specialist referral cases, and we are really looking forward to building relationships with them.
"We are lucky to have a great team of veterinary Specialists, nurses and support colleagues at VSS, who are all dedicated to offering the best service and care possible. We are all excited to see what the next few months will bring.
The centre, based at Deer Park in Livingston, will also provide a CPD programme and internship and residency opportunities to those in the profession.
Professor Dick White said: “Since its original inception, our vision for VSS has always been to create a world-class facility, with state-of-the-art technology and outstanding levels of care, and it feels great that we have finally been able to open the doors, welcome patients in and start on our journey.
"We hope the referral centre not only supports local vets and pets, but also fosters new talent and helps develop the next generation of veterinary professionals through our CPD and Internship offering. We are looking forward to what the future will hold."
Davies Veterinary Specialists (DVS), the Hertfordshire-based private small animal referral practice, has launched a pro bono scheme to help deliver the practice's multi-specialist care to deserving patients and clients.
All first opinion practices are eligible to apply for the scheme, which will allow an average of one patient per month to receive free treatment.
Clive Elwood, managing director of DVS said: "The DVS board was unanimous in its desire to introduce a pro bono scheme to help the needy, specifically those patients that are likely to achieve a full recovery following specialist care, but are otherwise precluded from referral because of their owners' particular circumstances."
Pro bono requests are open to all practices. They will be based on advocacy from the clinical head of the referring practice and on genuine need.
To find out more visit http://www.vetspecialists.co.uk/ or call Dr Clive Elwood on 01582 883950.
BEVA says it was aware, from both younger members and their employers, that there were some equine fields, for which the association had no courses, where newer graduates were lacking in clinical skills.
The new Equine Practice Fundamentals Programme comprises 10 individual CPD courses with a mix of lectures and hands-on practicals. BEVA says it builds on the broad training delivered by the universities to specifically provide the pragmatic knowledge and hands-on clinical skills needed by those in the early stages of an equine veterinary career.
The content was designed on the back of consultation with over 60 senior practitioners from across BEVA’s membership.
The average senior practitioner rated the likelihood that they would encourage recent graduates to attend the programme as 9/10 and BEVA says feedback on the initial course proposal was highly encouraging.
The courses cover:
David Mountford, Chief Executive of BEVA, said: "Because BEVA doesn’t seek to make a profit on its CPD we can deliver an outstanding programme that is both highly regarded and affordable. We anticipate that the series will become essential CPD for those looking to establish themselves in equine practice, for practices looking to support the development of new staff, and for employers looking to differentiate between candidates."
The first five courses will be running during 2018 and again in 2019 together with the remaining five. The full series of ten courses can be booked at a discounted rate. Alternatively, each course can be booked individually.
For further information visit https://www.beva.org.uk/Home/Education/CPD/The-Fundamentals-of-Equine-Practice
Charlie says that uniquely, the company offers feedback about samples submitted, with the aim of teaching veterinary staff the skills needed to interpret future samples themselves.
Cytovet is aimed at nurses and new grads who want to improve their cytology skills, vets who don’t have time to look at their own samples or have a tricky case they would like an additional opinion on, and those vets whose clients can’t afford the prices the big labs quote.
Charlie said: "I’m a vet with 16 years of clinical experience and a certAVP which focussed on small animal medicine and clinical pathology.
"I currently work in first opinion charity practice and have examined thousands of cytology samples over the years.
"I have been writing cytology reports for the practices I have worked for since 2012.
"I believe all vets and nurses should have the basic microscope skills required to help make more informed decisions for their patients, particularly in a world of escalating veterinary costs and antimicrobial resistance.
"I can examine both digital images and posted slides using a top-of-the-range trinocular digital microscope.
"All you need to do is submit the patient information and slides to me (digital images or actual slides) via my website and I will provide you with a report within 3-5 days."
Urgent turnaround is also available.
www.cytovet.co.uk
The manufacturer has identified that there is a potential for decreased levels of the preservative Chlorobutanol hemihydrate in the following batch: J2101-03 Expiry 11/2018.
Oxytobel is distributed in the UK by Bimeda UK. Veterinary practices that have purchased this batch number should contact Bimeda to arrange collection.
Any queries in relation to return of the product or credit for the product returned should be addressed to Kay Cowton, Bimeda UK Sales on 01248 725400 or email: uksales@bimeda.com
For further information on the recall please contact Bela-pharm GmbH & Co.KG: +49 (0) 44 41 873 294.
Thermo-insulated wellington boots to keep feet warm on farms during winter time are being launched by Bekina of Belgium in the UK and ROI.
Like the Bekina Steplite X boots designed for general farm work, the Thermolite cold weather wellie is moulded from polyurethane rather than traditional rubber or PVC. However, the Thermolite wellie also has extra thick uppers and soles, making them suitable for use by farmers and vets in temperatures down to minus 40C.
Wide fitting for extra comfort, Bekina Thermolites are supplied with a free pair of removable, insulated insoles. They are also available with safety toecaps.
For details Freephone AgriHealth 0800 731 2490,or visit http://www.bekina.be/
Virbac has launched a new 12 month version of Suprelorin, the reversible medical castration implant for dogs, widening the options for clients seeking an alternative to surgical castration.
Product manager Chris Geddes MRCVS said: "The launch of Suprelorin 12 gives practices the chance to offer dog owners a more convenient castration option. The implant renewal can now be included with their dog's annual boosters or health check.
"The slow-release implant is inserted at the back of the neck in the same manner as a microchip. There is no anaesthetic, no surgery and no scarring. The current implant, which contains 4.7mg active and lasts for around 6 months after insertion, will continue to be available for those wanting a more brief solution or as a trial.
"Deslorelin is a GnRH superagonist which causes suppression of LH/FSH, and therefore testosterone production, leading to temporary infertility."
For further information on Suprelorin/12, please call and ask to speak to one of our veterinary advisors on 01359 243243, or contact your local Virbac territory manager.
Prior to joining Fitzpatrick Referrals, Gerard was a Senior Lecturer in Internal Medicine at the University of Glasgow as well as Head of the Emergency Service and Director of both the Internship and ECVIM Residency Programmes. He is also a European and Royal College Recognised Specialist in Internal Medicine, and recently became one of few specialists in the world to have completed a 12 month Fellowship in Interventional Radiology at the Animal Medical Center in New York.
Gerard said: "When I returned to the UK, it was a natural fit for me to join Fitzpatrick Referrals. The team all share the same ethos and together I know we will be able to offer a truly world-class service to our patients and their family. I genuinely believe we will be able to change what is accepted as the gold standard of care for animals in the UK."
Fitzpatrick Referrals says its interventional radiology service performs minimally invasive procedures that are often considered the standard of care in human medicine, providing options for veterinary patients where conventional therapies are not associated with the best outcome.
Clinical Director of Oncology and Soft Tissue, Professor Nick Bacon said: "Gerard joining the team in Guildford opens new doors for our patients but more importantly we hope the disciplines of veterinary oncology and soft tissue surgery as a whole. He brings huge experience in interventional radiology solutions for portosystemic shunts, tracheal collapse and urinary calculi obstruction. Gerard is also key to developing our cancer care. Progress is not about ever bigger treatments chasing a cure; it can just as easily mean delivering palliative or curative-intent treatments in smarter ways, with less side-effects and lower morbidity. I am looking forward to watching our treatments evolve for a variety of tumours including urinary, liver, lung and head and neck. No cancer treatment is perfect, but we are striving for the best we can for the patient in front of us."
Noel Fitzpatrick said: "It remains my objective to build the greatest team of super-specialists on planet earth where we can offer all of the options to all of the animals and the families that love them all of the time. Gerard has a unique skill set that will not only complement our growing team, but will enhance the spectrum of treatments we can offer and which the families of animals throughout the UK and beyond really want. Increasingly people want the same level of care for their dogs and cats as we have for ourselves and our goal is to deliver exactly that with the very best team and facilities in the world today."
Fitzpatrick Referrals will be holding a Partners in Care CPD session on 25th May inviting vets to meet Dr Gerard McLauchlan and discover more about the interventional radiology service. To register your interest, contact Sarah on SarahC@fitzpatrickreferrals.co.uk.
Norbrook Laboratories has launched Noroseal, a new teat sealant containing a unique anti-infective ingredient.
The company says that Noroseal, a 2.6g intramammary suspension, is the only teat sealant in the market-place in Europe to contain a PVP-Iodine excipient.
Dr Barry McInerney MVB, MRCVS, PhD, Norbrook GB Veterinary Advisor said: "Noroseal, with its unique formulation, offers vets a proven barrier against intramammary infections during the dry period.
"New bacterial infections occur most often during the first three weeks of drying off because the cow's natural keratin plug is not completely formed. Indeed, approximately 50% of teat canals are still open for up to seven days after drying off. Noroseal Teat Sealant will mimic the cow's keratin teat barrier offering immediate protection against infection. Additionally, the anti-infective ingredient, PVP-Iodine, complements the effectiveness of the teat-sealant components in the teat canal barrier."
Norbrook says that the estimated annual cost of mastitis to the UK dairy industry is in excess of £168M with a single case of clinical mastitis costing farmers approximately £178.00 per cow.
Dr McInerney added: "Clinical mastitis is a costly business but one that can be avoided if timely action is taken. There are various treatments available for dealing with mastitis but studies have shown that the risk of clinical mastitis may be reduced by up to 50% by using a combination of teat sealant and dry cow intramammary therapy. Noroseal is therefore an ideal combination with Norbrook's dry cow therapies such as Noroclox DC, Bovaclox DC Xtra and Bovaclox DC."
Noroseal is available in packs of 24 or buckets of 120 units. A range of promotional material is also available to veterinary practices via the Norbrook Sales Team.
Ceva Animal Health has renamed Tildren, its tiludronate-based bisphosphonate infusion for the treatment of bone spavin in horses, as Equidronate.
Tiludronate has been used to treat bone spavin and navicular disease in Europe for many years and was licensed for bone spavin in the UK in 2008. Ceva says trials published last year show that horses suffering lameness caused by bone spavin can show marked improvement following treatment with an Equidronate infusion, in combination with controlled exercise.
Bone spavin is a chronic aseptic osteoarthritis of the distal tarsal joints and is considered to be one of the most common forms of hindlimb lameness in the horse. Horses with bone spavin experience abnormal bone remodeling changes. According to the company, Equidronate helps to modulate the osteoclasts to help prevent excessive bone removal and give the osteoblasts a chance to catch up. This in combination with adjusting levels of exercise helps to harmonise the bone adaptation needed for the horse to perform its athletic duties.
In the trials one in four horses showed marked improvement; two in four showed improvement, which, when combined with other treatment, enabled the horse to resume former levels of activity and one in four horses showed no response.
Ceva Animal Health has produced a range of explanatory leaflets for horse owners on bone spavin, navicular disease and sacroiliac disease, as well as a helpful booklet detailing the discharge procedures for horses that have been treated with Equidronate.
For free copies and for further product information contact your Ceva sales representative, ring Ceva on 01494 781510 or visit the website at http://www.ceva.uk.com/
The two best research projects were selected on the awards day with Sara Hillyer from the University of Bristol School of Veterinary Sciences winning the £1,000 top prize for her project on vascular endothelial glycocalyx shedding in clinical disease in cats and dogs.
Nicola Mawson from the Royal (Dick) School of Veterinary Studies won the £500 runner-up prize for her project on feline tooth resorptive lesions.
The other four successful candidates were Emily Clark from the University of Nottingham School of Veterinary Medicine & Science, Luca Fortuna from the Royal Veterinary College London, Jessica Lam from the Royal (Dick) School of Veterinary Studies, and Xaquin Castro Dopico from the Royal (Dick) School of Veterinary Studies. Each were awarded £1000 towards their research.
Michelle Townley, Veterinary Advisor and Bursary Co-ordinator at MSD Animal Health said: "We were delighted that we had so many applications this year and again the standard of research and presentation was extremely high. The winning students presented on a very wide range of research areas and selecting just two winners proved extremely hard. It is very encouraging to see such enthusiasm for research in the vets of the future."
Applicants were judged on the quality and clarity of their research project, and their ability to clearly communicate their conclusions.
Applications for the MSD Animal Health Veterinary Student Research Bursary 2018 will be opened early next year. For further information, visit: www.msd-animal-health.co.uk/company-overview/student-research-bursary.aspx
The online seminar, which equates to one hour’s CPD, features six UK experts in equine endocrinology, with the objective of supporting equine and mixed practice vets in using the clinical history to guide their interpretation of the basal ACTH test results and subsequent treatment decisions.
The speakers participating in the Equine Endocrine Pioneers Circle are:
Harry Carslake MA VetMB DipACVIM MRCVS: Senior lecturer in equine medicine at the University of Liverpool
Edd Knowles MA VetMB MVetMed DipECEIM MRCVS: Specialist in Equine internal medicine at Bell Equine Veterinary clinic
Professor Cathy McGowan BVSc DipVetClinStud MACVSc PhD DEIM DipECEIM FHEA MRCVS: Head of Department of Equine Clinical Science and Director of Veterinary Postgraduate Education at the University of Liverpool
Dr Nicola Menzies-Gow MA VetMB PhD DipECEIM Cert EM(Int Med) MRCVS: Reader in equine medicine at the Royal Veterinary College
Victoria South MA VetMB CertAVP(EM) DipECEIM MRCVS: Senior assistant at Liphook Equine Hospital
Nicola Steele BVM&S CertAVP(EM) MRCVS: Fyrnwy Equine Clinic and Director of Veterinary CPD (Equine and Large Animal)
The webinar considers when vets should test for PPID and decision-making on the best test to use, how to interpret grey zone results and also how to interpret problematic follow up tests. The experts have different opinions on some of these areas, allowing vets in practice to see the different ways in which cases can be viewed and managed.
These principles are then reinforced by the use of three clinical case scenarios with the patients all having the same basal ACTH result but a different selection of clinical signs.
Liz Barrett, equine business head at Boehringer Ingelheim said: "Since the launch of our Talk About Laminitis initiative in 2012, more than 50,000 horses have benefited from complimentary basal ACTH tests to aid the diagnosis of PPID, however two common areas of uncertainty in interpreting ACTH results still exist. Firstly, the interpretation of borderline, equivocal or ‘grey-zone’ results and when PPID treatment should or shouldn’t be recommended and secondly, the interpretation of follow-up ACTH test results and when to advise altering the treatment dose.
"The Equine Endocrine Pioneers Circle webinar allows vets to update their knowledge on this broad subject area and illustrates that there is often more than one way to approach the diagnosis, treatment and management of the PPID case."
To view the Equine Endocrine Pioneers Circle webinar on the Boehringer Academy visit https://www.boehringer-academy.co.uk/webinar/bil205
Dechra Veterinary Products has announced that Intubeaze Oromucosal Spray is now back in stock.
Intubeaze is used for local anaesthesia of the laryngeal mucosa of cats to facilitate endotracheal intubation by preventing the stimulation of the laryngeal reflex.
The product had gone out of stock due to a temporary manufacturing problem which has now been fixed.
Intubeaze is a clear solution containing 2% w/v lidocaine hydrochloride, with 0.1% w/v chlorocresol as an antimicrobial preservative. Intubeaze is now available through all wholesalers.
For further information on Intubeaze please contact Dechra on 01743 441 632 or visit www.dechra.co.uk.
The company points to research which showed that 42% of cats and 28% of dogs have lesions which are only detectable on x-ray1.
Failing to identify teeth with root lesions can have a significant impact on patient welfare, causing ongoing pain and eventual tooth loss.
The first priority for the CVS clinical improvement project was to review how effective its first opinion small animal practices were at using radiography in dental examinations.
In July 2021, only 16.2% of dental cases had radiography performed and clinicians were mostly using visual examination to guide decision making.
The project then identified the barriers to using dental radiography as: a lack of dental radiography equipment in a practice, a lack of clinician confidence in taking and interpreting the radiographs and a belief that pet owners would not want to pay for it.
To address the first issue, CVS installed new dental radiography machines at over 104 sites, at a cost of £615,000 over the course of the year.
The company then upskilled its vets and nurses in dental radiography - looking specifically at getting good quality radiographs and interpretation.
Finally, the company conducted an audit of each participating practice’s dental radiology data, updating it each month and sharing the results with the practices..
One year on, CVS says the data shows that 43% of dental cases in project practices are now using dental radiography as part of their consultation.
In the best cases, some practices have been using radiography in 100% of cases.
Hub Clinical Lead Deborah Komianos said: “When you open a patient’s mouth and look inside, seemingly normal teeth are oftentimes not normal.
"So vets and nurses can risk missing periodontal disease.
“Dental radiology has historically been underutilised but we believe it adds valuable information to dental consultations and is an important decision-making tool.
“We’re thrilled with the early results in our practices.
"It shows there’s been a real change of mind-set and behaviour towards using X-rays in dentistry – as well as increased confidence in execution."
Reference
Pets At Home Vet Group and Dick White Referrals have announced a strategic partnership in order to develop Pets at Home's strategy for providing specialist care.
Pets at Home says it is creating a new divisional structure comprised of the existing First Opinion Division (Vets4Pets and Companion Care joint venture practices) and the new Specialist Division, which comprises Dick White Referrals, Northwest Surgeons, Anderson Moores, and Eye Vet Referrals.
Dick White has been appointed Clinical Director of the new Specialist Division.
Dick will remain as a shareholder in Dick White Referrals. He and three of the Specialist clinicians - Giunio Bruto Cherubini, Federico Corletto and Rob Foale - will retain 24% of the practice.
Sally Hopson, CEO of Pets at Home Vet Group said: "We are delighted to have attracted a colleague of Dick White’s pedigree to join us, not only to help drive the future growth of Dick White Referrals, but also to play a key role in developing our Specialist Division. Professor White is a key figure in the development of the Specialist Veterinary segment; he has trained many of the leading Specialist veterinary practitioners. This is a tremendous step forward for the Vet Group. I’m also very pleased that Professor White and his colleagues have chosen to remain as equity partners in Dick White Referrals."
Dick said: "Forming this strategic partnership provides great opportunities for us to continue to develop Dick White Referrals as a world class referrals centre with a team of leading Veterinary Specialists. I am delighted to be working with a partner that shares our vision for Dick White Referrals and is committed to supporting its future development. Joining the Board of the Specialist Division will allow me to provide clinical leadership and governance across the division, input into the formulation of strategy and support M&A activity and veterinary recruitment."
VetFinders will recruit for permanent and locum positions for veterinary practices throughout the UK, from administration roles through to nursing staff and vets.
The agency has been founded by a man called Chris Worthington who previously built an engineering recruitment firm called Qualtech Resourcing.
Alongside Chris in the VetFinders team are recruiters Gabrielle Dawson and Martin Wilson, both with over 15 years’ experience in recruitment, Chris’s wife Anna, who is charge of accounting and payroll, and administrator Suzy Buttress.
Chris said: "VetFinders is a business with a purpose, a business with a force for good and a business with a double bottom line! Our approach is totally unique in the industry and it’s what sets us apart. Candidates are already hearing about our message and registering with VetFinders rather than other agencies.
"We have chosen four specific charities and our support for them does not stop at the point of donation. We will also be working closely with them, funding specific projects and working on their front line."
The chosen charities are:
Hope Pastures, in Leeds, which rescues, rehabilitates and re-homes horses, ponies and donkeys.
Moorview Rescue in Harrogate, which has re-homed almost 2000 dogs in the UK since it was set up as a registered charity in 2009.
Nuzzlets, a small charity based near Great Ouseburn in York which specialises in giving loving homes to unwanted animals and enabling young people free access to them for therapy and education.
Blue Cross.
When a candidate is placed by VetFinders, the client can choose which of the four charities they want a percentage of their fee to be donated to. The client and placed candidate will then be given regular updates of how their money has benefitted children and animals, including through photos, videos, emails and website updates.
For more information, visit: https://www.vetfinders.co.uk/
Photo: Top (L-R): Martin Wilson - Veterinary Recruitment Consultant, Chris Worthington - Managing Director. Bottom (L-R): Gabrielle Dawson - Veterinary Recruitment Consultant, Anna Worthington - Finance and Payroll Manager and Suzy Buttress - Administrator.
Alice and Mariella, who co-authored the book Cracking the Menopause, met with MPs earlier this month to present the goals of their campaign: education for all on the menopause, an end to scaremongering, prescribing women with the correct medication and making HRT affordable and accessible to all.
Vets Now says 88% of its 1800 employees are women, 28% of whom are aged over 40, when they could be perimenopausal, menopausal or postmenopausal.
The company's new app offers its employees video consultations with health experts, health and fitness programmes, and support with mental health and nutrition.
Vet's Now says it's the starting point for a wider menopause support plan being launched later in the year which will include steps to help manage mental wellbeing at work, menopause support hubs and encouraging a culture which talks honestly about menopause.
Laura Black, Head of Health, Safety and Wellbeing, said: “Women over 50 are the fastest growing demographic in the workplace and sadly it’s estimated that almost 900,000 women in the UK have quit their jobs due to the menopause.
“We are committed to creating an understanding workplace for employees going through the perimenopause and menopause and want to make sure they feel supported by us at all times.
“We've launched Peppy to help our colleagues take control of their health and get the answers they need from experts, anytime, anywhere.
"The app is free to access for all employees and their partners.
“We’ve been working hard on formulating a menopause support package for staff over the past couple of years and we’re really proud that we’re one of the first major veterinary businesses to make this step change.
"We’d encourage other businesses in the sector to look at similar plans for their colleagues.”
While the drive to launch Peppy was initially to support the Vets Now Menopause policy, it also provides support for fertility, pregnancy, early parenthood and men’s health.
For more information on Peppy visit www.peppy.health.
Virbac Animal Health has launched Allerderm, a topical spot on product designed to rebuild the epidermal barrier in dogs and cats with skin problems.
According to the company, Allerderm Spot-On contains a mimic of the normal lamellar lipids found in the stratum corneum: essential fatty acids, ceramides and cholesterol.
Virbac Product Manager Chris Geddes MRCVS said: The "outside-in" theory of inflammatory skin disease is now widely accepted - that is, the belief that a faulty epidermal barrier is the primary problem, allowing penetration of allergens which then triggers inflammation in the underlying skin.
"A healthy epidermal barrier is designed to keep in water and moisture, and keep out allergens and pathogens. The 'barrier repair' approach has been developed in human medicine and is now proving true in companion animal care.
"It is currently possible to help restore this barrier with oral essential fatty acid supplements like Complederm and with Allermyl shampoo, but this is an exciting new addition to the armoury."
Mr Geddes added: "In a study of allergic dogs1, researchers found that Allerderm spot on caused the level of lipids on the stratum corneum to return to almost the level of normal dogs."
Allerderm Spot-On is applied along the back of the dog or cat initially at weekly intervals, eventually reducing to monthly applications. It is available in packs of 6 pipettes in 2ml (suitable for cats and dogs less than 10kg) and 4ml (suitable for dogs over 10kg).
For further information on Allerderm Spot-On, contact your local Virbac territory manager or call Virbac on 01359 243243.
Reference1. Effects of a Topically Applied Preparation of Epidermal Lipids on the Stratum Corneum Barrier of Atopic Dogs, A. Piekutowska, D. Pin, C.A. Réme, H. Gatto and M. Haftek, Journal of Comparative Pathology 2008, Vol. 138, 197-203
The disease had been identified as a priority by the Wales Animal Health and Welfare Framework Group.
Further details will be announced in the coming months following ongoing discussions with industry representatives.
The Minister said: "Sheep scab has significant economic consequences for sheep producers and animal welfare issues for sheep. It is one of the most contagious disease of sheep in Wales and eradicating it is a priority for us and the industry.
"I’m pleased to be able to announce £5m Rural Development Programme funding will be used to help support the industry tackle the disease. Eradicating the disease has the potential to deliver significant lasting economic benefits for the sector at a particularly challenging time as we prepare to leave the European Union."
The Swadlincote and Melbourne-based IVC practice worked with a Great Workplaces by BVA accreditor during the pilot of the new scheme, to demonstrate its strengths against an accreditation framework covering four key themes: health and wellbeing, leadership and management, culture and learning and development.
In the report, the accreditor was particularly impressed by the practice’s strong leadership and management; its emphasis on accommodating flexibility for team members in various forms; a robust teamworking ethos; and a focus on continuous improvement.
British Veterinary Association President Elizabeth Mullineaux said: “We’re delighted to see Swadlincote Veterinary Centre become the first veterinary workplace to achieve Gold accreditation through Great Workplaces by BVA scheme.
"Congratulations to the whole practice team for this incredible recognition.
“Creating positive working environments and targeting areas for improvement are the key to tackling ongoing workforce challenges around recruitment and retention.
"We hope this first Gold accreditation inspires others to strive towards gaining recognition as workplaces where vet teams thrive.”
Ingrid Stevenson, Clinical Director at Swadlincote Veterinary Centre, said: “While we knew the practice was doing well, we didn’t go into this process expecting Gold at all.
"My practice manager and I were just both really keen to get some feedback and to find out what more we could do to help the team.
“We have several clinical accreditations in the practice, but it is the team that are responsible for achieving these and maintaining the high standards.
"I believe the team should be looked after, recognised and rewarded for their hard work and going above and beyond when necessary.
"The team were really pleased when I shared the news.
"It has certainly been good for team morale and a positive outcome to share with potential new recruits. '
“The accreditation process was a thorough assessment of the practice and our accreditor made us feel all at ease during the interviews.
"While we achieved Gold, which was unexpected, we have also learnt of areas to develop further over the coming months.
"Overall, it was a positive experience for our practice.”
www.bva.co.uk/take-action/good-veterinary-workplaces/
Pfizer has divested itself of its animal health business unit, which has become a stand-alone company called Zoetis. The new company unveiled its vision for Europe, Africa and the Middle East (EuAfME) region at a press conference in Paris last week.
The company says it aims to have its products, services and people as the most valued by animal health customers around the region, and the world.
Alejandro Bernal, Zoetis Executive Vice President and Area President for the EuAfME region said: "We are united around this shared vision, and we strive every day to help customers meet their real-world challenges through quality medicines and vaccines, complemented by diagnostic products, genetic tests and a range of services," said "As the largest standalone company in the industry, we are dedicated solely to animal health and focusing on our core business so our customers can grow theirs."
In addition to working closely with customers, Zoetis said it strives to collaborate with universities and other research organisations, to help advance the animal health sector and those who raise and care for animals. One example of this is the partnership with the University of Stirling, one of the leading research organisations, based in Scotland.
Professor Randolph Richards, from Stirling said: "Academia is increasingly realising the benefits of working with industry on research projects, and is concentrating on those with more direct impact rather than on pure research. In our own case, Zoetis has been able to provide resources which were otherwise unavailable to us, with funding opportunity being provided through the UK Technology Strategy Board."
Boehringer Ingelheim Vetmedica has launched Pexion (imepitoin) a novel treatment for canine idiopathic epilepsy.
Canine epilepsy can affect up to 5% of dogs6. In most dogs diagnosed with idiopathic epilepsy no underlying cause for the seizures can be found. While the condition can affect any dog, it is more common in young (one to five year old), purebred dogs such as Labradors, Golden Retrievers, German Shepherds, Boxers, Vizlas, Beagles, English Springer Spaniels, Irish Setters, Poodles and Dachshunds.
Boehringer says Pexion has a highly targeted mode of action1-3 to suppress a dog's seizures. It starts to work within a few hours and reaches steady state within three days4,5. Boehringer claims this will make it easier to stabilise epileptic patients. It also says there is no evidence of hepatotoxicity or liver-associated enzyme elevation, so repeated blood tests for liver enzymes or therapeutic levels are no longer required.4,5
Pexion is available in 100 mg and 400 mg tablets. The tablets are white, scored and divisible in half. Both tablet strengths are available in 100 tablet packs from veterinary wholesalers.
Jemima Mead, brand manager at Boehringer said: "Pexion is a ground-breaking new product which gives vets a new first-line treatment option for dogs with idiopathic epilepsy, improving the lives of newly diagnosed epileptic dogs and their owners by reducing the number of seizures and their impact on the patient's life".
To support the launch of the new product, Boehringer hosted an epilepsy webinar presented by neurologist Dr Holger Volk DVM PhD DipECVN FHEA MRCVS, recognised RCVS and European Specialist in Veterinary Neurology. The webinar is now available on demand at www.bi-academy.co.uk.
For further information on Pexion visit www.pexion.co.uk, contact your local Boehringer Ingelheim territory manager or telephone +44 (0)1344 746959.
References
Vet-AI's automated triage app offers instant advice to pet owners 24/7, early detection of health issues and advice as to whether they need to speak to a vet.
For the blinded test, which was conducted in April 2025, three UK veterinary surgeons reviewed the responses from Vet-AI, Gemini 2.0 and ChatGPT 4.0 to 48 simulated enquiries from owners.
The vets evaluated each on clinical accuracy, triage effectiveness and the subjective criteria of factuality, integrity, safety, empathy and readability.
Vet-AI’s Large Language Model (LLM) achieved an accuracy score of 81%, surpassing Gemini (69%) and ChatGPT (50%).
Vet-AI’s model also stopped triage at the correct point in 81% of cases according to the vets, compared with Gemini’s 75% and ChatGPT’s 56%.
Vet-AI’s tool also outperformed the leading LLMs on subjective measures, delivering more empathetic, thorough and factual responses to pet owners.
Samantha Webster, Chief Veterinary Officer at Vet-AI said: “These latest results are a significant milestone in the development of automated triage.
"We’re proving we can provide trustworthy online pet care by combining clinical and technical expertise.
"This tool can support the wider industry too, engaging more pet owners in the first step of vet care, ensuring their pets get the care they need - whether in practice or remotely.
"We know that an increasing percentage of the UK pet population is struggling to access veterinary care.
"Whilst AI will never replace a vet, the use of innovative technology can break down the barrier to access, leading to more pets getting the care they need, when they need it."
“With this level of clinical accuracy and technical innovation, we're helping to bring great pet care to more people. As well as helping to create more demand for vet services by making the triage of pets as accurate as possible,” said Paul Hallett, Vet-AI founder and exec chair.
https://www.vet-ai.com/automated-triage
Lots of April Fool's Day gags involving animals this year...
watch?v=1kC0OI9MYZc
The Sun reported that Sir Richard Branson's health club chain, Virgin Active, is launching a new gym for dogs only, to combat the pet obesity epidemic. Alton Towers supposedly launched a new rollercoaster ride for dogs only. Meanwhile, Pasante, a condom manufacturer, launched the 'condog', though this seems to be a variation on an idea that has been around for a while now.
My favourites, though, were two April fools unrelated to animals. The first was from Cadbury's, made more believable by the fact that it was planted in the Southampton Echo. The second was the announcement by BMW that Dr. Noit All, the company's Head of Innovation, had developed a fuel-saving system called Magnetic Tow Technology (MTT). Readers were invited to keep abreast with future developments from BMW by emailing Dr. Noit All's colleague at uve.vollenvorit@bmw.co.uk.